Status:

COMPLETED

Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier

Lead Sponsor:

Remko P. Bosgraaf

Conditions:

Asherman Syndrome

Intrauterine Adhesion

Eligibility:

FEMALE

30+ years

Phase:

NA

Brief Summary

Evaluate the formation of adhesions after third-generation endometrial ablation, with and without the intrauterine adhesion barrier.

Detailed Description

The application of endometrial ablation (EA) has significantly increased in the past 10 years. It is an effective treatment for heavy menstrual bleeding with functional aetiology. However, the risk of...

Eligibility Criteria

Inclusion

  • Patient with refractory heavy menstrual bleeding scheduled for endometrial ablation with Novasure system
  • Women 30 years old or older;
  • Subjects who are willing to provide a written informed consent as approved by the applicable Ethics Committee / IRB prior to participating in this clinical investigation.
  • Subjects who can comply with the study follow-up and other study requirements.

Exclusion

  • Cavity length \<4 or \>8
  • Perforation during ablation procedure
  • Previous adhesiolysis procedure or diagnosis of Asherman's disease.
  • Abnormal uterine cavity at the time of ablation according to ESHRE classification I to V such as unicornis, bicornis, septate, duplex
  • History of cervical or endometrial cancer
  • Active pelvic infection or history of pelvic peritonitis
  • Known contraindication or hypersensitivity to Womed Leaf component
  • Current participation in another clinical investigation that has not yet received the primary endpoint
  • Any other condition that makes participation in the study contrary to the patient's best interests.

Key Trial Info

Start Date :

November 11 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 5 2024

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT05414760

Start Date

November 11 2022

End Date

February 5 2024

Last Update

February 7 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Catharina Hospital

Eindhoven, Netherlands, 5623EJ

2

St. Jans Gasthuis

Weert, Netherlands, 6001BE